Memantine, an antagonist of the NMDA glutamate receptor, affects cell proliferation, differentiation and the intracellular cycle and induces apoptosis in Trypanosoma cruzi.
Chagas' disease is caused by the protozoan parasite Trypanosoma cruzi and affects approximately 10 million people in endemic areas of Mexico and Central and South America. Currently available chemotherapies are limited to two compounds: Nifurtimox and Benznidazole. Both drugs reduce the symptom...
Saved in:
Main Authors: | Flávia Silva Damasceno (Author), María Julia Barisón (Author), Elisabeth Mieko Furusho Pral (Author), Lisvane Silva Paes (Author), Ariel Mariano Silber (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2014-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi.
by: Higo Fernando Santos Souza, et al.
Published: (2019) -
The glutamine synthetase of Trypanosoma cruzi is required for its resistance to ammonium accumulation and evasion of the parasitophorous vacuole during host-cell infection.
by: Marcell Crispim, et al.
Published: (2018) -
The Trypanosoma cruzi Protein TcHTE Is Critical for Heme Uptake.
by: Marcelo L Merli, et al.
Published: (2016) -
Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer's Disease, in Silico Trials
by: Dariusz Świetlik, et al.
Published: (2022) -
Inducible nitric oxide inhibitors block NMDA antagonist-stimulated motoric behaviors and medial prefrontal cortical glutamate efflux
by: Hadley C Bergstrom, et al.
Published: (2015)